BDX
$BDX
Becton, Dickinson and Company
Medical technology company making syringes, diagnostics, and infusion systems.
Healthcare$197.88
-0.46 (-0.23%)
Day Range$197.05 - $199.94
Prev Close$198.34
Analyst Rating
Buy
8 Buy / 7 Hold / 1 Sell
Price Target
$188.33
-4.8% downside
Subscribers
0
Tracking this ticker
Latest Report
Analysis from Oct 31, 2026
BDX: Healthcare Cash Flows vs Mixed Valuation
Becton, Dickinson and Company ($BDX) sits near its 52-week high with solid cash flow and a dependable dividend, while analysts' mean target suggests limited upside. This report reviews fundamentals, valuation, catalysts and risks heading into the November earnings release.
Oct 31, 2026
Previous Reports
Keep exploring
- draft Becton, Dickinson and into a free practice contest: How to put the stock you just researched into a contest lineup at no real-money risk
- the healthcare sector brief for context on Becton, Dickinson and's peers: Today's sector-level news and moves around the stock